focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCALL.L Regulatory News (CALL)

  • There is currently no data for CALL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Directors and Strategy Update

14 Apr 2011 07:00

RNS Number : 8783E
Zenergy Power PLC
14 April 2011
 

 

14th April 2011

 

 

Zenergy Power plc

("Zenergy" or "the Company")

New Directors & Strategy Update

 

Following the announcement made yesterday, the Board is providing additional background on the new directors and an interim strategy update.

 

The new directors:

 

Simon Cleaver

Simon is an entrepreneur and highly experienced director who has built, developed and sold a number of successful companies in both the private and the public arenas. He has specialist knowledge of acquiring and turning around companies or assets, often under distressed circumstances.

 

Businesses that he has built and sold include Serve Logic plc, Business Serve plc, RDP Ltd and Dalehart Ltd. Prior to setting out on his own, Simon worked in the City for Bailey Shatkin working in the field of derivatives. He was educated in the UK and studied Chemistry at Leicester Polytechnic.

 

David Whelan

David Whelan is the Chief Executive of the Cloverleaf Group, the second largest shareholder in Zenergy. The Cloverleaf Group is a privately held alternative investment group focused primarily on venture capital and private equity investments in healthcare, life sciences and breakthrough technologies. 

 

David is a director of the following Cloverleaf Group portfolio companies: AgaMatrix, Inc; Block Shield Corporation Ltd; Identitas, Inc, MD Datacor, Inc. and was recently appointed Chairman of Medcenter Holdings, Inc. David was also the founding manager of the Group's investment in Zenergy Power Plc. 

 

Prior to joining the Cloverleaf Group, David was Vice President of Corporate Development with the Virgin Group in the US and the UK. David led the development and start up of the largest ever Virgin Group company - Virgin America, a U.S. based low cost airline.

 

David was previously an investment banker in London and Sydney with Goldman Sachs & Company and before that Deutsche Bank. Starting his career at Price Waterhouse in the firm's Corporate Finance division in Sydney, David qualified as a Chartered Accountant of Australia. David has a Bachelor of Laws (Honours) and Bachelor of Commerce from Bond University in Queensland, Australia.

 

Georg Oehm

Georg is one of the founders of Mellinckrodt & Cie, Zug, Switzerland. Prior to this he was MD and Partner in a financial communications boutique in Frankfurt am Main. He was also one of the founders and the first MD of the German CFD Association e.V.

 

Before that Georg worked five years on special restructuring projects following five years at Metallgesellschaft AG in the Corporate Development and M&A department.

 

He finished his PhD in the faculty of economics and social sciences at the University of Kiel, following studies of business economics in Mainz and Kiel. Georg started his professional education with a bank apprenticeship at Dresdner Bank AG in Frankfurt am Main.

 

 

Strategy Update

 

The Company will provide shareholders with a more detailed strategic update in the near future once a detailed review of the Company's operations has been conducted. Meanwhile, the new executive Chairman, Simon Cleaver, comments:

 

 "The changed Board firmly believes that to have sold the Company in its entirety at the current time would not have maximised the potential value of Zenergy. High Temperature Superconductivity (HTS) has the ability to provide a step change in efficiency levels for electronic power distribution networks (grids), electrical metal heating and renewable power generation and Zenergy is almost certainly the global leader in the field.

 

"Whilst we need to get our sleeves rolled up and conduct an immediate review of the Company before we issue any detailed plans, our initial strategy is based on using the Company's specialist IP and knowledge to form joint ventures and strategic alliances to help commercialise Zenergy's products.

 

"We are pleased to have concluded these Board changes. The Board will now be focused on giving the business a new and very clear strategic direction with the aim of restoring shareholder value and working with industry partners to continue developing what the Board believes is a suite of market leading products."

 

 

-Ends-

 

Further information

 

Simon Cleaver, Chairman

Zenergy Power Plc

+ 44 1344 667 347

Stephen Mischler

Matrix Corporate Capital

+ 44 20 3206 7000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAIJMFTMBJBBLB
Date   Source Headline
23rd Nov 20167:00 amRNSDirector/PDMR Shareholding
22nd Nov 20163:30 pmRNSDirector/PDMR Shareholding
15th Nov 201612:30 pmRNSDirector/PDMR Shareholding
19th Oct 20167:00 amRNSHolding(s) in Company
18th Oct 20163:54 pmRNSHolding(s) in Company
17th Oct 20165:13 pmRNSHolding(s) in Company
17th Oct 201610:54 amRNSHolding(s) in Company
14th Oct 20167:00 amRNSDirectorate Change
7th Oct 20167:00 amRNSAppointment of Bullhorn Partner Director
5th Oct 20167:00 amRNSUpdate Re. Placing
30th Aug 20168:40 amRNSHolding(s) in Company
25th Aug 20169:40 amRNSHolding(s) in Company
25th Aug 20168:30 amRNSDirector/PDMR Dealings
24th Aug 201610:30 amRNSResult of General Meeting
18th Aug 20168:30 amRNSHolding(s) in Company
5th Aug 20165:13 pmRNSDirector/PDMR Dealings
5th Aug 20167:00 amRNSInterim results announcement
12th Jul 20165:52 pmRNSChange of Registered Address
6th Jun 20167:00 amRNSCloudCall releases new CloudCall Local Presence
27th May 20169:10 amRNSChange of Name
23rd May 20162:47 pmRNSResult of AGM
16th May 20167:00 amRNSContract Win
15th Apr 20161:48 pmRNSHolding(s) in Company
23rd Mar 20162:51 pmRNSDirector/PDMR Shareholding
22nd Mar 20169:47 amRNSAnnual Financial Report
22nd Mar 20167:00 amRNSFinal Results
21st Mar 20163:09 pmRNSHolding(s) in Company
16th Mar 20167:00 amRNSChange of Adviser and Notification of Results
17th Feb 20167:00 amRNSNew loan facility
22nd Jan 20169:53 amRNSHolding(s) in Company
20th Jan 20167:00 amRNSTrading Update
5th Jan 201610:15 amRNSHolding(s) in Company
17th Dec 20157:00 amRNSHolding(s) in Company
1st Dec 20157:00 amRNSBoard Restructuring
25th Nov 20152:20 pmRNSDirector/PDMR Shareholding
24th Nov 20154:06 pmRNSDirector/PDMR Shareholding
20th Nov 20151:27 pmRNSDirector/PDMR Shareholding
19th Nov 20154:14 pmRNSDirector/PDMR Shareholding
19th Nov 201510:11 amRNSDirector/PDMR Shareholding
21st Oct 201511:20 amRNSHolding(s) in Company
29th Sep 20155:47 pmRNSIssue of Equity and Total Voting Rights
24th Sep 20159:04 amRNSDirector/PDMR Shareholding
21st Sep 20151:32 pmRNSDirector/PDMR Shareholding
21st Sep 20158:39 amRNSDirector/PDMR Shareholding
15th Sep 20157:00 amRNSInterim Results
1st Sep 201510:44 amRNSHolding(s) in Company
27th Aug 20157:00 amRNSDirectorate Changes and Notification of Results
5th Aug 20159:10 amRNSHolding(s) in Company
4th Aug 20158:55 amRNSHolding(s) in Company
4th Jun 201510:50 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.